Kidney cancer is the eighth most commonly diagnosed cancer in the United States, and nearly one-third of patients have locally advanced or metastatic disease at presentation. Historically, survival outcomes for patients with advanced disease have been poor. In recent years, several novel targeted agents have emerged for the management of advanced renal cell carcinoma that have changed treatment paradigms. At the same time, surgical therapy continues to have a critical role in the management of selected patients. Recent medical and surgical advances have improved the prognosis for patients with a diagnosis of advanced disease. This review provides an overview of the current treatment landscape for patients with advanced renal cell carcinoma.
Clinical advances in hematology & oncology : H&O. 2018 Jun [Epub]
Abhinav Khanna, Alice Crane, Nitin Yerram, Daniel Sun, Kyle Ericson, Scott D Lundy, Robert Abouassaly
Cleveland Clinic Glickman Urologic & Kidney Institute, Cleveland, Ohio.